CLINICAL RESEARCH: CARDIAC EFFECTS OF DIABETES
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
Luuk J. Rijzewijk, MD*,
Rutger W. van der Meer, MD ,*,
Johannes W.A. Smit, MD, PhD ,
Michaela Diamant, MD, PhD*,
Jeroen J. Bax, MD, PhD ,
Sebastiaan Hammer, MSc,
Johannes A. Romijn, MD, PhD,
Albert de Roos, MD, PhD and
Hildo J. Lamb, MD, PhD,*
* Department of Endocrinology, VU University Medical Center, Amsterdam, the Netherlands
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
Department of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Manuscript received May 26, 2008;
revised manuscript received July 25, 2008,
accepted July 30, 2008.
* Reprint requests and correspondence: Dr. Rutger W. van der Meer or Hildo J. Lamb, Department of Radiology, C2S, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands (Email: R.W.van_der_meer{at}lumc.nl).
Objectives: The purpose of this study was to compare myocardial triglyceride content and function between patients with uncomplicated type 2 diabetes mellitus (T2DM) and healthy subjects within the same range of age and body mass index (BMI), and to study the associations between myocardial triglyceride content and function.
Background: T2DM is a major risk factor for cardiovascular disease. Increasing evidence is emerging that lipid oversupply to cardiomyocytes plays a role in the development of diabetic cardiomyopathy, by causing lipotoxic injury and myocardial steatosis.
Methods: Myocardial triglyceride content and myocardial function were measured in 38 T2DM patients and 28 healthy volunteers in the same range of age and BMI by proton magnetic resonance (MR) spectroscopy and MR imaging, respectively. Myocardial triglyceride content was calculated as a percentage relative to the signal of myocardial water.
Results: Myocardial triglyceride content was significantly higher in T2DM patients compared with healthy volunteers (0.96 ± 0.07% vs. 0.65 ± 0.05%, p < 0.05). Systolic function did not significantly differ between both groups. Indexes of diastolic function, including the ratio of maximal left ventricular early peak filling rate and the maximal left ventricular atrial peak filling rate (E/A) and E peak deceleration, were significantly impaired in T2DM compared with those in healthy subjects (1.08 ± 0.04 ml/s2 x 10–3 vs. 1.24 ± 0.06 ml/s2 x 10–3 and 3.6 ± 0.2 ml/s2 x 10–3 vs. 4.4 ± 0.3 ml/s2 x 10–3, respectively, p < 0.05). Multivariable analysis indicated that myocardial triglyceride content was associated with E/A and E peak deceleration, independently of diabetic state, age, BMI, heart rate, visceral fat, and diastolic blood pressure.
Conclusions: Myocardial triglyceride content is increased in uncomplicated T2DM and is associated with impaired left ventricular diastolic function, independently of age, BMI, heart rate, visceral fat, and diastolic blood pressure.
Key Words: magnetic resonance imaging • diastolic function • diabetes mellitus • myocardial lipids • spectroscopy
|
Abbreviations and Acronyms
| | A = atrial contraction | | BMI = body mass index | | E = early diastolic filling phase | | E/A = ratio of maximal left ventricular early peak filling rate and the maximal left ventricular atrial peak filling rate | | E/Ea = estimation of left ventricular filling pressures | | LV = left ventricle/ventricular | | MR = magnetic resonance | | MRI = magnetic resonance imaging | | (NE)FA = (nonesterified) fatty acids | | T2DM = type 2 diabetes mellitus |
|
Related Articles
-
Steatosis and Diastolic Dysfunction: The Skinny on Myocardial Fat
- Jason B. Lindsey and Steven P. Marso
J. Am. Coll. Cardiol. 2008 52: 1800-1802.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A36.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. Bonapace, G. Perseghin, G. Molon, G. Canali, L. Bertolini, G. Zoppini, E. Barbieri, and G. Targher
Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
Diabetes Care,
February 1, 2012;
35(2):
389 - 395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Utz, S. Engeli, S. Haufe, P. Kast, M. Hermsdorf, S. Wiesner, M. Pofahl, J. Traber, F. C. Luft, M. Boschmann, et al.
Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women
Heart,
October 1, 2011;
97(19):
1585 - 1589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Inoue, K. Kobayashi, T. Inoguchi, N. Sonoda, M. Fujii, Y. Maeda, Y. Fujimura, D. Miura, K.-i. Hirano, and R. Takayanagi
Reduced Expression of Adipose Triglyceride Lipase Enhances Tumor Necrosis Factor {alpha}-induced Intercellular Adhesion Molecule-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C-dependent Activation of Nuclear Factor-{kappa}B
J. Biol. Chem.,
September 16, 2011;
286(37):
32045 - 32053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Bakermans, T. R. Geraedts, M. van Weeghel, S. Denis, M. Joao Ferraz, J. M. F. G. Aerts, J. Aten, K. Nicolay, S. M. Houten, and J. J. Prompers
Fasting-Induced Myocardial Lipid Accumulation in Long-Chain Acyl-CoA Dehydrogenase Knockout Mice Is Accompanied by Impaired Left Ventricular Function
Circ Cardiovasc Imaging,
September 1, 2011;
4(5):
558 - 565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Iozzo
Myocardial, Perivascular, and Epicardial Fat
Diabetes Care,
May 1, 2011;
34(Supplement_2):
S371 - S379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. van der Zijl, G. H. Goossens, C. C. M. Moors, D. H. van Raalte, M. H. A. Muskiet, P. J. W. Pouwels, E. E. Blaak, and M. Diamant
Ectopic Fat Storage in the Pancreas, Liver, and Abdominal Fat Depots: Impact on {beta}-Cell Function in Individuals with Impaired Glucose Metabolism
J. Clin. Endocrinol. Metab.,
February 1, 2011;
96(2):
459 - 467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. T. Ng, V. Delgado, M. Bertini, R. W. van der Meer, L. J. Rijzewijk, S. Hooi Ewe, H.-M. Siebelink, J. W. A. Smit, M. Diamant, J. A. Romijn, et al.
Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes Mellitus
Circulation,
December 14, 2010;
122(24):
2538 - 2544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Desrois, K. Clarke, C. Lan, C. Dalmasso, M. Cole, B. Portha, P. J. Cozzone, and M. Bernard
Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury
Am J Physiol Heart Circ Physiol,
November 1, 2010;
299(5):
H1679 - H1686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Andersson, P. Sogaard, S. Hoffmann, P. R. Hansen, A. Vaag, A. Major-Pedersen, T. F. Hansen, J. Bech, L. Kober, C. Torp-Pedersen, et al.
Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes
Eur. J. Endocrinol.,
October 1, 2010;
163(4):
593 - 599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Rijzewijk, J. T. Jonker, R. W. van der Meer, M. Lubberink, H. W. de Jong, J. A. Romijn, J. J. Bax, A. de Roos, R. J. Heine, J. W. Twisk, et al.
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
J. Am. Coll. Cardiol.,
July 13, 2010;
56(3):
225 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Harmancey, C. R. Wilson, N. R. Wright, and H. Taegtmeyer
Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis
J. Lipid Res.,
June 1, 2010;
51(6):
1380 - 1393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gropler, R. S. B. Beanlands, V. Dilsizian, E. D. Lewandowski, F. S. Villanueva, and M. C. Ziadi
Imaging Myocardial Metabolic Remodeling
J. Nucl. Med.,
May 1, 2010;
51(Supplement_1):
88S - 101S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Taegtmeyer
Tracing Cardiac Metabolism In Vivo: One Substrate at a Time
J. Nucl. Med.,
May 1, 2010;
51(Supplement_1):
80S - 87S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Paulus and J. J.M. van Ballegoij
Treatment of Heart Failure With Normal Ejection Fraction: An Inconvenient Truth!
J. Am. Coll. Cardiol.,
February 9, 2010;
55(6):
526 - 537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Anderson, A. P. Kypson, E. Rodriguez, C. A. Anderson, E. J. Lehr, and P. D. Neufer
Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart
J. Am. Coll. Cardiol.,
November 10, 2009;
54(20):
1891 - 1898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Iozzo, R. Lautamaki, R. Borra, H.-R. Lehto, M. Bucci, A. Viljanen, J. Parkka, V. Lepomaki, R. Maggio, R. Parkkola, et al.
Contribution of Glucose Tolerance and Gender to Cardiac Adiposity
J. Clin. Endocrinol. Metab.,
November 1, 2009;
94(11):
4472 - 4482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Chantler and E. G. Lakatta
Role of Body Size on Cardiovascular Function: Can We See the Meat Through the Fat?
Hypertension,
September 1, 2009;
54(3):
459 - 461.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. van der Meer, L. J. Rijzewijk, H. W.A.M. de Jong, H. J. Lamb, M. Lubberink, J. A. Romijn, J. J. Bax, A. de Roos, O. Kamp, W. J. Paulus, et al.
Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus
Circulation,
April 21, 2009;
119(15):
2069 - 2077.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Lindsey and S. P. Marso
Steatosis and Diastolic Dysfunction: The Skinny on Myocardial Fat
J. Am. Coll. Cardiol.,
November 25, 2008;
52(22):
1800 - 1802.
[Full Text]
[PDF]
|
|
|
|
